Supported by

Stable CAD (Coronary artery disease)

Find all the latest content on stable coronary artery disease (stable CAD) published on this website.

A complex and changing disease state requiring wide expertise, stable CAD can involve a diverse range of underlying chronic or evolutionary stages involving full use of all available tools, devices and techniques like those for invasive imaging and functional assessment. Taking into account underlying comorbidities such as diabetes is critical. Advances in imaging techniques, as well as the use of adjunctive pharmacotherapy, vascular access or invasive interventions such as bypass surgery, are important, as are understanding bleeding risks, all of which can be found here…

Filtered By
Stable CAD

361 results

All you need to know about physiological assessment of coronary artery disease

Despite guidelines that recommend the use of physiological assessment in coronary artery disease, it is only used in less than 10% of cases. Join Emanuele Barbato and Carlos Collet as they look at some of the reasons behind this low rate of implementation. They describe a...

Physiological assessment of coronary artery disease

All you need to know about high-bleeding risk (HBR) patients

22 May 2019 – From EuroPCR 2019

Consult this session to learn more about current evidence and new recommendations on high bleeding risk patients and how to better identify them.

All you need to know about high-bleeding risk (HBR) patients

Bridging the gap of oral P2Y12 inhibition for PCI with cangrelor: what does the new data tell us?

22 May 2019 – From EuroPCR 2019

Consult this session to learn through studies and clinical cases more about contemporary pharmacological strategies with intravenous antiplatelet therapy in PCI for STEMI, NSTEMI and complex stable coronary artery disease patients.

Bridging the gap of oral P2Y12 inhibition for PCI with cangrelor: what does the new data tell us?

What every interventional cardiologist should know about new cardiovascular drugs

22 May 2019 – From EuroPCR 2019

Consult this session to learn all about the major impact of several new cardiovascular drugs in patients with coronary artery disease, diabetes and other high-risk conditions, such as PCSK9, DAPT, and more!

What every interventional cardiologist should know about new cardiovascular drugs

The evolving role of physiology and imaging - Tools to support your efforts: diagnostic to post-PCI

22 May 2019 – From EuroPCR 2019

Consult this session to learn more about post-PCI physiology assessments, microcatheter-based post-stent FFR procedures and post-PCI intravascular imaging in high-definition.

The evolving role of physiology and imaging - Tools to support your efforts: diagnostic to post-PCI

How intracoronary imaging can improve your patients' outcomes

22 May 2019 – From EuroPCR 2019

Consult this session to discover tips and tricks to interpret IVUS and OCT images correctly, and to learn more about which imaging modality will help in which situation in your cathlab and how the latest clinical data may influence your daily practice.

How intracoronary imaging can improve your patients' outcomes

This case would have been different without intracoronary imaging

22 May 2019 – From EuroPCR 2019

Consult this session to discover compelling clinical cases where intracoronary imaging was very useful to treat it efficiently, and learn more about its role in ACS, PCI, CTO, and more!

This case would have been different without intracoronary imaging

New approaches in the functional assessment of coronary stenosis

22 May 2019 – From EuroPCR 2019

Consult this session to learn all about the new approaches in the functional assessment of coronary stenosis, such as the Quantitative Flow Ratio, the FAST EXTEND study, and more!

New approaches in the functional assessment of coronary stenosis

Cardiovascular outcomes of SGLT-2 inhibitors and GLP-1 agonists in patients with diabetes and coronary artery disease

22 May 2019 – From EuroPCR 2019

Consult this session to learn more about the cardiovascular outcomes of SGLT-2 inhibitors and GLP-1 agonists in patients with diabetes and coronary artery disease, and the clinical strategy for treatment implementation.

Cardiovascular outcomes of SGLT-2 inhibitors and GLP-1 agonists in patients with diabetes and coronary artery disease

Intracoronary imaging in daily practice: cases where OCT did help... a lot!

22 May 2019 – From EuroPCR 2019

Consult this session to learn more about how to use intracoronary imaging in your daily practice, to manage several cases such as late PCI, CTO revascularization, and more!

Intracoronary imaging in daily practice: cases where OCT did help... a lot!